Olema Pharmaceuticals, Inc.OLMANASDAQ
Loading
Operating Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+18.6%
5Y CAGR+52.7%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
+18.6%/yr
vs +167.8%/yr prior
5Y CAGR
+52.7%/yr
Recent deceleration
Acceleration
-149.2pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
8.3x
Strong expansion
Streak
2 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $178.70M | +25.6% |
| 2024 | $142.26M | +35.5% |
| 2023 | $104.96M | -1.9% |
| 2022 | $106.99M | +49.7% |
| 2021 | $71.49M | +232.3% |
| 2020 | $21.52M | +397.7% |
| 2019 | $4.32M | +107.9% |
| 2018 | $2.08M | - |